Major adverse cardiovascular event definitions used in observational analysis of administrative databases: a systematic review
E Bosco, L Hsueh, KW McConeghy… - BMC Medical Research …, 2021 - Springer
Background Major adverse cardiovascular events (MACE) are increasingly used as
composite outcomes in randomized controlled trials (RCTs) and observational studies …
composite outcomes in randomized controlled trials (RCTs) and observational studies …
Polypharmacy management in older patients
RW Hoel, RMG Connolly, PY Takahashi - Mayo Clinic Proceedings, 2021 - Elsevier
Medications to treat disease and extend life in our patients often amass in quantities,
resulting in what has been termed “polypharmacy.” This imprecise label usually describes …
resulting in what has been termed “polypharmacy.” This imprecise label usually describes …
Association of statin use with all-cause and cardiovascular mortality in US veterans 75 years and older
Importance Data are limited regarding statin therapy for primary prevention of atherosclerotic
cardiovascular disease (ASCVD) in adults 75 years and older. Objective To evaluate the …
cardiovascular disease (ASCVD) in adults 75 years and older. Objective To evaluate the …
Use of high dose cyproterone acetate and risk of intracranial meningioma in women: cohort study
A Weill, P Nguyen, M Labidi, B Cadier, T Passeri… - bmj, 2021 - bmj.com
Objective To assess the risk of meningioma associated with use of high dose cyproterone
acetate, a progestogen indicated for clinical hyperandrogenism. Design Observational …
acetate, a progestogen indicated for clinical hyperandrogenism. Design Observational …
Chronic diseases, health conditions and risk of COVID-19-related hospitalization and in-hospital mortality during the first wave of the epidemic in France: a cohort …
L Semenzato, J Botton, J Drouin, F Cuenot… - The Lancet Regional …, 2021 - thelancet.com
Background From the beginning of the COVID-19 pandemic, age (most importantly), male
gender and various comorbidities were found to be associated with severe forms of COVID …
gender and various comorbidities were found to be associated with severe forms of COVID …
Statin liver safety in non‐alcoholic fatty liver disease: A systematic review and metanalysis
Aims Statin liver safety in non‐alcoholic fatty liver disease (NAFLD) patients is not well
defined. We analysed differences in liver function tests, including alanine transaminase …
defined. We analysed differences in liver function tests, including alanine transaminase …
[HTML][HTML] Editor's Choice--European Society for Vascular Surgery (ESVS) 2024 Clinical Practice Guidelines on the Management of Asymptomatic Lower Limb …
J Nordanstig, CA Behrendt, I Baumgartner… - European Journal of …, 2024 - Elsevier
BIOTRONIK's First in Man study of the Passeo-18 LUX drug releasing PTA Balloon Catheter
vs. the uncoated Passeo-18 PTA balloon catheter in subjects requiring revascularisation of …
vs. the uncoated Passeo-18 PTA balloon catheter in subjects requiring revascularisation of …
[HTML][HTML] Assessment and management of statin-associated muscle symptoms (SAMS): A clinical perspective from the National Lipid Association
BA Warden, JR Guyton, AC Kovacs, JA Durham… - Journal of clinical …, 2023 - Elsevier
Statin-associated muscle symptoms (SAMS) are the most common form of statin intolerance
and are associated with increased risk of cardiovascular events that manifest from statin …
and are associated with increased risk of cardiovascular events that manifest from statin …
Coenzyme Q10 for Patients With Cardiovascular Disease: JACC Focus Seminar
AE Raizner, MA Quiñones - Journal of the American College of Cardiology, 2021 - jacc.org
Abstract Coenzyme Q10 (CoQ10) is a naturally occurring compound that is found in animals
and all humans. It has a fundamental role in cellular energy production. Although it is …
and all humans. It has a fundamental role in cellular energy production. Although it is …
[HTML][HTML] Dyslipidemia management for primary prevention of cardiovascular events: Best in-clinic practices
N Thongtang, R Sukmawan, EJB Llanes… - Preventive medicine …, 2022 - Elsevier
Dyslipidemia is a fundamental risk factor for cardiovascular diseases (CVDs) and can
worsen the prognosis, if unaddressed. Lipid guidelines are still evolving as dyslipidemia is …
worsen the prognosis, if unaddressed. Lipid guidelines are still evolving as dyslipidemia is …